[Question] New Zealand — has anyone got a straight answer on LC-MS
method development. That is the whole post, but I will justify it. Everything else people worry about in c/dosinglogs is downstream of it. Titration speed, early fullness, the endless dose arguments — most of it resolves if you sort method development out first, and almost nobody does. I say this having got it wrong…
Yeah, the chromatogram profile matters more than the headline number.
Retitled to remove editorialising. Put the evidence in the body.
a round-robin on baseline integration would be genuinely useful
area% and mass% are not the same and this whole post conflates them
Strongly agree. Largest single impurity tells a different story than total purity.